Replimune Group, Inc. (REPL)
Market Open
26 Oct, 06:08 PM
$
12. 50
+1.04
+9.075%
$
1.08B Market Cap
- P/E Ratio
- Div Yield
80,329 Volume
-3.52 Eps
$ 11.46
Previous Close 
Want to track REPL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Replimune Group, Inc. (REPL) Statistics
Valuation metrics
Market Cap 1.08B
Enterprise value 1.01B
Trailing P/E (ttm) -3.64
Forward P/E -2.51
PEG ratio -0.6
Price/Sales (ttm) -
Price/Book (mrq) 10.51
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.5
Overview
Shares outstanding 79.63M
Float 58.68M
Shares short 21.16M
% Held by insiders 0.03%
% Held by institutions 0.89%
Average volume (10 days) 1.71M
Average volume (90 days) 3.91M
Price summary
52-Week low 1.5
52-Week high 16.33
Beta 0.12
50-Day moving average 12.8
200-Day moving average 9.76
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.18%
Return on equity -1.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -318.88M
Net income to common (ttm) -314.85M
Diluted EPS (ttm) -3.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 269.14M
Total cash per share (mrq) 2.02
Total debt (mrq) 76.35M
Total Debt/Equity (mrq) 1.06
Current ratio (mrq) 5.23%
Book value per share (mrq) 1.09
Cash Flow
Cash flow statement -277.91M
Levered free cash flow (LFCF) -172.75M
2026 © Marketlog. All Rights Reserved.
